ATRA
AtaraยทNASDAQ
--
--(--)
--
--(--)
ATRA Profile
Atara Biotherapeutics, Inc.
A pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for solid tumors, hematologic cancers and autoimmune disease
1280 Rancho Conejo Blvd, Thousand Oaks, CA 91320
--
Atara Biotherapeutics, Inc., was incorporated in Delaware on August 22, 2012. The company is a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop translational therapies for patients with cancer and autoimmune diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
